万嘉集团(00401)发布中期业绩，股东应占亏损71.2万港元

Core Viewpoint - Wan Jia Group (00401) reported a loss attributable to shareholders of HKD 712,000 for the six months ending September 30, 2025, despite a revenue increase of 2.4% to HKD 85.706 million, driven by growth in the blood dialysis business [1] Financial Performance - Revenue for the period was HKD 85.706 million, reflecting a year-on-year increase of 2.4% [1] - The company recorded a loss attributable to shareholders of HKD 712,000, compared to a profit of HKD 1.256 million in the same period last year [1] - Basic loss per share was HKD 0.127 [1] Business Segment Analysis - The increase in revenue was primarily driven by the growth in the blood dialysis business [1]